Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-124608
Filing Date
2026-03-25
Accepted
2026-03-25 20:02:09
Documents
1
Period of Report
2026-03-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 12421
  Complete submission text file 0001193125-26-124608.txt   15784
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA
Business Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA 650-924-9424
TCG Crossover GP II, LLC (Reporting) CIK: 0001969280 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 26794027

Mailing Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA
Business Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA 650-924-9424
TCG Crossover Fund II, L.P. (Reporting) CIK: 0001969281 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 26794026

Mailing Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA
Business Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA 650-924-9424
TCG Crossover Fund III, L.P. (Reporting) CIK: 0002062644 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 26794024

Mailing Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA
Business Address 245 LYTTON AVE., SUITE 350 PALO ALTO CA 650-924-9424
TCG Crossover GP III, LLC (Reporting) CIK: 0002062816 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39635 | Film No.: 26794025